MCID: BRD004
MIFTS: 50

Borderline Personality Disorder

Categories: Mental diseases

Aliases & Classifications for Borderline Personality Disorder

MalaCards integrated aliases for Borderline Personality Disorder:

Name: Borderline Personality Disorder 12 77 56 45 15 74

Classifications:



External Ids:

Disease Ontology 12 DOID:10930
ICD9CM 36 301.83
MeSH 45 D001883
NCIt 51 C92633
SNOMED-CT 69 20010003
ICD10 34 F60.3
UMLS 74 C0006012

Summaries for Borderline Personality Disorder

Disease Ontology : 12 A personality disorder that involves a prolonged disturbance of personality function characterized by depth and variability of moods.

MalaCards based summary : Borderline Personality Disorder is related to alexithymia and bipolar disorder. An important gene associated with Borderline Personality Disorder is SLC6A4 (Solute Carrier Family 6 Member 4), and among its related pathways/superpathways are Peptide ligand-binding receptors and cAMP signaling pathway. The drugs Citalopram and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and amygdala, and related phenotypes are behavior/neurological and homeostasis/metabolism

Wikipedia : 77 Borderline personality disorder (BPD), also known as emotionally unstable personality disorder (EUPD),... more...

Related Diseases for Borderline Personality Disorder

Diseases related to Borderline Personality Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 135, show less)
# Related Disease Score Top Affiliating Genes
1 alexithymia 30.7 COMT HTR1A SLC6A4
2 bipolar disorder 30.5 BDNF COMT HTR1A HTR2A SLC6A4 TPH1
3 eating disorder 30.4 BDNF COMT HTR2C SLC6A4
4 antisocial personality disorder 30.3 COMT HTR1B MAOA SLC6A4
5 dysthymic disorder 30.3 HTR2A MAOA SLC6A4
6 bulimia nervosa 30.3 BDNF COMT HTR1B HTR2A SLC6A4
7 substance dependence 30.2 BDNF HTR1B MAOA SLC6A4
8 conduct disorder 30.2 COMT MAOA SLC6A4 TPH1
9 schizophreniform disorder 30.2 COMT PRL
10 atypical depressive disorder 30.2 HTR2A MAOA SLC6A4
11 pain - chronic 30.1 COMT NR3C1
12 anorexia nervosa 30.1 BDNF COMT HTR2A PRL SLC6A4
13 alcohol abuse 30.1 BDNF HTR2A PRL SLC6A4
14 traumatic brain injury 30.1 BDNF COMT
15 avoidant personality disorder 30.0 MAOA SLC6A4 TPH1
16 oppositional defiant disorder 30.0 COMT MAOA SLC6A4
17 intermittent explosive disorder 30.0 HTR1A PRL SLC6A4
18 personality disorder 29.9 AVPR1A BDNF COMT HTR1A HTR1B HTR2A
19 substance abuse 29.9 BDNF COMT HTR1B MAOA PRL SLC6A4
20 schizoaffective disorder 29.9 BDNF COMT HTR2A PRL SLC6A4
21 amnestic disorder 29.8 BDNF HTR1A
22 social phobia 29.8 HTR1A MAOA PRL SLC6A4
23 fibromyalgia 29.8 COMT HTR2A PRL SLC6A4
24 disease of mental health 29.7 BDNF COMT HTR1A HTR2A HTR2C MAOA
25 panic disorder 29.6 COMT HTR1A HTR2A MAOA SLC6A4
26 depression 29.5 BDNF HTR1A HTR2A HTR2C MAOA NR3C1
27 attention deficit-hyperactivity disorder 29.1 BDNF COMT HTR1A HTR1B HTR2A HTR2C
28 bipolar i disorder 29.1 BDNF COMT HTR1A HTR2A HTR2C SLC6A4
29 post-traumatic stress disorder 29.0 BDNF COMT FKBP5 HTR2A MAOA NR3C1
30 generalized anxiety disorder 28.9 BDNF COMT HTR1A HTR2A MAOA SLC6A4
31 schizophrenia 28.8 BDNF COMT HTR1A HTR1B HTR2A HTR2C
32 chronic fatigue syndrome 28.7 COMT HTR1A HTR2A MAOA NR3C1 SLC6A4
33 anxiety 28.6 BDNF COMT HTR1A HTR2A HTR2C MAOA
34 psychotic disorder 28.6 BDNF COMT HTR1A HTR2A HTR2C PRL
35 endogenous depression 28.4 BDNF HTR1A HTR2A MAOA NR3C1 SLC6A4
36 obsessive-compulsive disorder 28.2 BDNF COMT HTR1A HTR1B HTR2A HTR2C
37 mood disorder 28.1 BDNF COMT HTR1A HTR1B HTR2A HTR2C
38 mental depression 28.1 BDNF COMT FKBP5 HTR1A HTR2A HTR2C
39 alcohol dependence 27.9 BDNF COMT HTR1A HTR1B HTR2A HTR2C
40 major depressive disorder 27.6 BDNF COMT FKBP5 HTR1A HTR1B HTR2A
41 multiple personality disorder 11.4
42 impulse control disorder 11.1
43 pol iii-related leukodystrophies 10.6
44 bronchopulmonary dysplasia 10.6
45 cognitive function 1, social 10.4
46 mammographic density 10.3 COMT PRL
47 phobia, specific 10.3 COMT MAOA
48 alcoholic psychosis 10.2 HTR2A SLC6A4
49 early-onset schizophrenia 10.2 BDNF HTR2A
50 tardive dyskinesia 10.2 COMT HTR2A
51 schizoid personality disorder 10.2 HTR1A HTR2A
52 sexual disorder 10.2 HTR1A PRL SLC6A4
53 hypoactive sexual desire disorder 10.2 HTR1A HTR2A
54 substance-induced psychosis 10.2 HTR1A HTR2A
55 dystonia 1, torsion, autosomal dominant 10.2 COMT MAOA
56 dissociative disorder 10.2
57 specific developmental disorder 10.2 BDNF COMT SLC6A4
58 migraine without aura 10.2 HTR1A PRL SLC6A4
59 polycystic ovary syndrome 10.1
60 narcissistic personality disorder 10.1
61 somatoform disorder 10.1
62 drug-induced mental disorder 10.1 HTR1A HTR2A
63 paraphilia disorder 10.1 MAOA PRL
64 drug psychosis 10.1 HTR1A HTR2A
65 kleptomania 10.1 HTR1A MAOA SLC6A4
66 agoraphobia 10.1 HTR1A MAOA SLC6A4
67 pathological gambling 10.1 HTR2A MAOA SLC6A4
68 major affective disorder 1 10.1
69 major affective disorder 8 10.1
70 major affective disorder 7 10.1
71 major affective disorder 9 10.1
72 schizotypal personality disorder 10.1
73 central nervous system disease 10.1 BDNF HTR2A SLC6A4
74 kleine-levin hibernation syndrome 10.1 COMT TPH1
75 alacrima, achalasia, and mental retardation syndrome 10.0
76 body dysmorphic disorder 10.0
77 pelvic inflammatory disease 10.0
78 obsessive-compulsive personality disorder 10.0
79 allergic hypersensitivity disease 10.0
80 dementia 10.0
81 drug dependence 10.0
82 cocaine dependence 10.0
83 heroin dependence 10.0
84 nelson syndrome 10.0 NR3C1 PRL
85 phobic disorder 10.0 COMT HTR1A MAOA SLC6A4
86 ocular dominance 10.0 BDNF HTR2C
87 acth-secreting pituitary adenoma 10.0 NR3C1 PRL
88 pulmonary hypertension 10.0 HTR1B SLC6A4 TPH1
89 serotonin syndrome 9.9 HTR1A HTR2A MAOA SLC6A4
90 schizophrenia 5 9.9 HTR1A HTR2A HTR2C
91 postpartum depression 9.9 BDNF COMT MAOA PRL SLC6A4
92 aplasia cutis congenita, nonsyndromic 9.8
93 blood group, colton system 9.8
94 lithium transport 9.8
95 carney complex, type 1 9.8
96 schizencephaly 9.8
97 aging 9.8
98 frontotemporal dementia 9.8
99 pituitary adenoma, prolactin-secreting 9.8
100 caronte 9.8
101 body mass index quantitative trait locus 1 9.8
102 macular dystrophy with central cone involvement 9.8
103 brain injury 9.8
104 burns 9.8
105 asperger syndrome 9.8
106 sexual masochism 9.8
107 dissociative amnesia 9.8
108 depersonalization disorder 9.8
109 hypochondriasis 9.8
110 ehlers-danlos syndrome 9.8
111 somatization disorder 9.8
112 factitious disorder 9.8
113 cannabis dependence 9.8
114 dermatitis 9.8
115 melancholia 9.8
116 movement disease 9.8
117 delusional disorder 9.8
118 cyclothymic disorder 9.8
119 learning disability 9.8
120 dissociative seizures 9.8
121 pseudobulbar affect 9.8
122 opioid addiction 9.8
123 headache 9.8
124 adrenal cortex disease 9.8 NR3C1 PRL
125 autism spectrum disorder 9.8 AVPR1A BDNF HTR2A SLC6A4
126 tobacco addiction 9.8 COMT HTR2A MAOA SLC6A4 TPH1
127 paranoid schizophrenia 9.8 BDNF COMT HTR2A MAOA SLC6A4
128 psychosexual disorder 9.8 HTR1A HTR2A HTR2C SLC6A4
129 periodic limb movement disorder 9.8 HTR1A HTR2A HTR2C SLC6A4
130 premature ejaculation 9.7 HTR1A HTR1B HTR2C SLC6A4
131 autism 9.6 AVPR1A BDNF HTR1A HTR2A SLC6A4
132 sudden infant death syndrome 9.6 BDNF HTR1A HTR2A MAOA SLC6A4 TPH1
133 brunner syndrome 9.6 COMT HTR1A HTR1B MAOA SLC6A4 TPH1
134 parkinson disease, late-onset 9.5 BDNF COMT HTR1A HTR2A MAOA SLC6A4
135 migraine with or without aura 1 9.0 COMT HTR1A HTR1B HTR2A HTR2C MAOA

Comorbidity relations with Borderline Personality Disorder via Phenotypic Disease Network (PDN): (showing 9, show less)


Acute Cystitis Anxiety
Cerebral Atherosclerosis Dependent Personality Disorder
Dysthymic Disorder Hypertension, Essential
Hypothyroidism Major Depressive Disorder
Schizophreniform Disorder

Graphical network of the top 20 diseases related to Borderline Personality Disorder:



Diseases related to Borderline Personality Disorder

Symptoms & Phenotypes for Borderline Personality Disorder

MGI Mouse Phenotypes related to Borderline Personality Disorder:

47 (showing 7, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.22 AVPR1A BDNF COMT FKBP5 HTR1A HTR1B
2 homeostasis/metabolism MP:0005376 10 AVPR1A BDNF COMT FKBP5 HTR1A HTR2C
3 cardiovascular system MP:0005385 9.97 AVPR1A COMT HTR1A HTR1B MAOA NR3C1
4 endocrine/exocrine gland MP:0005379 9.92 AVPR1A BDNF COMT HTR1B HTR2A NR3C1
5 integument MP:0010771 9.63 BDNF HTR2C NR3C1 PRL SLC6A4 TPH1
6 muscle MP:0005369 9.5 AVPR1A HTR1B HTR2A HTR2C NR3C1 SLC6A4
7 nervous system MP:0003631 9.28 AVPR1A BDNF COMT HTR1A HTR2C MAOA

Drugs & Therapeutics for Borderline Personality Disorder

Drugs for Borderline Personality Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 126, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Citalopram Approved Phase 4,Phase 2,Not Applicable 59729-33-8 2771
2
Dopamine Approved Phase 4,Phase 2,Not Applicable 62-31-7, 51-61-6 681
3
Risperidone Approved, Investigational Phase 4,Not Applicable 106266-06-2 5073
4
Lamotrigine Approved, Investigational Phase 4 84057-84-1 3878
5
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
6
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
7 Omega 3 Fatty Acid Phase 4
8 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Not Applicable
9 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Not Applicable
10 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Not Applicable
11 Antipsychotic Agents Phase 4,Phase 3,Phase 2,Not Applicable
12 Antidepressive Agents Phase 4,Phase 3,Phase 2,Not Applicable
13 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
14 Neurotransmitter Uptake Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
15 Serotonin Uptake Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
16 Serotonin Agents Phase 4,Phase 3,Phase 2,Not Applicable
17 Antidepressive Agents, Second-Generation Phase 4,Phase 2,Not Applicable
18 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
19 Parasympatholytics Phase 4,Phase 2,Not Applicable
20 Muscarinic Antagonists Phase 4,Phase 2,Not Applicable
21 Antiparkinson Agents Phase 4,Phase 2,Not Applicable
22 Cholinergic Antagonists Phase 4,Phase 2,Not Applicable
23 Autonomic Agents Phase 4,Phase 3,Phase 2,Not Applicable
24 Cholinergic Agents Phase 4,Phase 2,Not Applicable
25 Dopamine Antagonists Phase 4,Phase 2,Not Applicable
26 Serotonin Antagonists Phase 4,Phase 2,Not Applicable
27 Dopamine Agents Phase 4,Phase 2,Not Applicable
28 Anticonvulsants Phase 4,Phase 3,Not Applicable
29 Calcium, Dietary Phase 4
30 Sodium Channel Blockers Phase 4
31 Diuretics, Potassium Sparing Phase 4
32 calcium channel blockers Phase 4
33 Hormones Phase 4,Phase 2,Not Applicable
34 Cytochrome P-450 Enzyme Inhibitors Phase 4
35 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
36
Serotonin Investigational, Nutraceutical Phase 4,Phase 3,Phase 2,Not Applicable 50-67-9 5202
37
Ethanol Approved Phase 3,Phase 2,Not Applicable 64-17-5 702
38
Naltrexone Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 16590-41-3 5360515
39
Selegiline Approved, Investigational, Vet_approved Phase 3 14611-51-9 5195 26757
40
Olanzapine Approved, Investigational Phase 3,Not Applicable 132539-06-1 4585
41 Narcotic Antagonists Phase 3,Phase 2,Not Applicable
42 Narcotics Phase 3,Phase 2,Not Applicable
43 Quetiapine Fumarate Phase 3,Phase 2 111974-72-2
44 Antiemetics Phase 3,Not Applicable
45 Gastrointestinal Agents Phase 3,Not Applicable
46 Analgesics, Opioid Phase 3,Not Applicable
47 Anti-Infective Agents, Local Phase 3,Phase 2
48 Anti-Infective Agents Phase 3,Phase 2,Phase 1
49
Acetaminophen Approved Phase 2 103-90-2 1983
50
Ziprasidone Approved Phase 2 146939-27-7 60854
51
Oxytocin Approved, Vet_approved Phase 2,Phase 1,Not Applicable 50-56-6 53477758 439302
52
Lithium carbonate Approved Phase 2 554-13-2
53
Hydrocortisone Approved, Vet_approved Phase 2,Not Applicable 50-23-7 5754
54
Hydrocortisone acetate Approved, Vet_approved Phase 2,Not Applicable 50-03-3
55
Acetylcysteine Approved, Investigational Phase 2,Phase 1 616-91-1 12035
56
Brexpiprazole Approved, Investigational Phase 2 913611-97-9 11978813
57
Acetylcholine Approved, Investigational Phase 2 51-84-3 187
58
Midazolam Approved, Illicit Phase 2 59467-70-8 4192
59
Ketamine Approved, Vet_approved Phase 2 6740-88-1 3821
60
Mifepristone Approved, Investigational Phase 2 84371-65-3 55245
61
Glutamic Acid Approved, Nutraceutical Phase 2 56-86-0 33032
62 Analgesics Phase 2
63 Analgesics, Non-Narcotic Phase 2
64 Antipyretics Phase 2
65 Contraceptives, Oral Phase 2,Not Applicable
66 Contraceptive Agents Phase 2,Not Applicable
67 Serotonin Receptor Agonists Phase 2
68 Pharmaceutical Solutions Phase 2
69 Oxytocics Phase 2,Phase 1,Not Applicable
70 Antimanic Agents Phase 2,Not Applicable
71 GABA Agents Phase 2,Not Applicable
72 Hydrocortisone hemisuccinate Phase 2,Not Applicable
73 Anti-Inflammatory Agents Phase 2,Not Applicable
74 Hydrocortisone-17-butyrate Phase 2,Not Applicable
75 Hydrocortisone 17-butyrate 21-propionate Phase 2,Not Applicable
76 Protective Agents Phase 2,Phase 1
77 Expectorants Phase 2,Phase 1
78 N-monoacetylcystine Phase 2,Phase 1
79 Antiviral Agents Phase 2,Phase 1
80 Free Radical Scavengers Phase 2,Phase 1
81 Antidotes Phase 2,Phase 1
82 Antioxidants Phase 2,Phase 1
83 Respiratory System Agents Phase 2,Phase 1
84 Dopamine agonists Phase 2
85 Neuromuscular Agents Phase 2
86 Acetylcholine Release Inhibitors Phase 2
87 Botulinum Toxins, Type A Phase 2
88 abobotulinumtoxinA Phase 2
89 Botulinum Toxins Phase 2
90 Anesthetics, Intravenous Phase 2
91 Hypnotics and Sedatives Phase 2
92 Excitatory Amino Acids Phase 2
93 GABA Modulators Phase 2
94 Anesthetics Phase 2
95 Excitatory Amino Acid Antagonists Phase 2
96 Anesthetics, Dissociative Phase 2
97 Anti-Anxiety Agents Phase 2
98 Adjuvants, Anesthesia Phase 2
99 Anesthetics, General Phase 2
100 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
101 Contraceptives, Postcoital Phase 2
102 Hormone Antagonists Phase 2
103 Luteolytic Agents Phase 2
104 glucocorticoids Phase 2
105 Vitamins Phase 1
106
Guanfacine Approved, Investigational Not Applicable 29110-47-2 3519
107
Methylphenidate Approved, Investigational Not Applicable 113-45-1 4158
108
Valproic Acid Approved, Investigational Not Applicable 99-66-1 3121
109
Cocaine Approved, Illicit 50-36-2 446220 5760
110
Morphine Approved, Investigational Not Applicable 57-27-2 5288826
111
Melatonin Approved, Nutraceutical, Vet_approved Not Applicable 73-31-4 896
112
Inulin Approved, Investigational, Nutraceutical Not Applicable 9005-80-5 24763
113 Adrenergic alpha-Agonists Not Applicable
114 Adrenergic Agonists Not Applicable
115 Adrenergic Agents Not Applicable
116 Antihypertensive Agents Not Applicable
117 Adrenergic alpha-2 Receptor Agonists Not Applicable
118 Central Nervous System Stimulants Not Applicable
119 Dopamine Uptake Inhibitors Not Applicable
120 Contraceptives, Oral, Combined Not Applicable
121 Opiate Alkaloids Not Applicable
122 Buprenorphine, Naloxone Drug Combination Not Applicable
123 Detox adjuvant
124 Arginine Vasopressin Not Applicable
125 Vasopressins Not Applicable
126 Acidophilus Not Applicable

Interventional clinical trials:

(showing 166, show less)
# Name Status NCT ID Phase Drugs
1 Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder Unknown status NCT00437099 Phase 4 Omacor®;Placebo
2 Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder Completed NCT00634062 Phase 4 Lamotrigine;Placebo
3 Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder Completed NCT00533117 Phase 4 Fluoxetine
4 Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder Completed NCT00834834 Phase 4 Fluoxetine;Citalopram
5 Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder Completed NCT00204347 Phase 4 risperidone
6 Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder Completed NCT00178061 Phase 4
7 BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder Completed NCT00538135 Phase 3
8 Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD) Completed NCT00880919 Phase 3 quetiapine extended-release;Placebo
9 Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder Completed NCT01912391 Phase 3 Selegiline;Placebo (for Selegiline)
10 Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder Completed NCT00122070 Phase 3 Quetiapine Fumarate
11 Olanzapine in Patients With Borderline Personality Disorder Completed NCT00091650 Phase 3 Olanzapine;placebo
12 Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder Completed NCT00088036 Phase 3 Olanzapine
13 The Short-Term MBT Project Recruiting NCT03677037 Phase 3
14 Naltrexone in Borderline Personality Disorder Terminated NCT00124839 Phase 3 Naltrexone
15 Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence Withdrawn NCT00463775 Phase 3 Topiramate
16 Acetaminophen and Social Processes Unknown status NCT02108990 Phase 2 Acetaminophen
17 Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment Completed NCT02125942 Phase 1, Phase 2
18 Ziprasidone in the Treatment of Borderline Personality Disorder Completed NCT00635921 Phase 2 ziprasidone;Placebo
19 Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Completed NCT01103180 Phase 2 Escitalopram
20 Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients Completed NCT00254748 Phase 2 Quetiapine fumarate;Placebo
21 Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder Completed NCT01133301 Phase 2 Naltrexone;Placebo
22 Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder Completed NCT00145678 Phase 2
23 Treating PTSD in Patients With Borderline Personality Disorder Completed NCT01081314 Phase 1, Phase 2
24 Treatment of Suicidal Women With Borderline Personality Disorder Completed NCT00183651 Phase 2
25 Oxytocin as Adjunctive Therapy for Schizophrenia Completed NCT01699997 Phase 2 Oxytocin;Placebo
26 Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms Completed NCT01189812 Phase 2 Lithium Carbonate;Placebo;Citalopram
27 Cognitive Therapy for PTSD in Addiction Treatment Completed NCT00685451 Phase 1, Phase 2
28 Brexpiprazole in Borderline Personality Disorder Recruiting NCT03418675 Phase 2 Rexulti;Placebo
29 A Novel Drug for Borderline Personality Disorder Recruiting NCT02097706 Phase 2 NMDA receptor antagonist (active drug)
30 Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD) Recruiting NCT02728778 Phase 2 incobotulinumtoxin A
31 Ketamine in Borderline Personality Disorder Recruiting NCT03395314 Phase 2 Ketamine;Midazolam
32 Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders Recruiting NCT02824627 Phase 2 Oxytocin;Placebo
33 Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder Not yet recruiting NCT03209102 Phase 2
34 Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Terminated NCT01212588 Phase 2 mifepristone;Placebo
35 N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD Terminated NCT00539188 Phase 2 N-Acetylcysteine;placebo
36 Creativity Group for Borderline Personality Disorder Unknown status NCT01343550 Phase 1
37 Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder Unknown status NCT00269139 Phase 1
38 20 Weeks DBT Group Skills Training Study Completed NCT01193205 Phase 1
39 Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents Completed NCT01111734 Phase 1 fMRI
40 Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Recruiting NCT02149823 Phase 1 Syntocinon 24 Intranasal Units (IU);Syntocinon 40 Intranasal Units (IU);Intranasal Placebo
41 Trial of Effect of High-frequency Transcranial Magnetic Stimulation in the Management of Borderline Personality Disorder Unknown status NCT01602497 Not Applicable
42 Event Related Potentials in Borderline Personality Disorder and Major Depression Unknown status NCT01469663
43 Emotional Reaction and Self Injury in Patients With Borderline Personality Disorder and Healthy Controls Unknown status NCT03149926
44 Promoting Recovery Processes in Women With Borderline Personality Disorder Using a Dynamic Cognitive Intervention Unknown status NCT01531634 Not Applicable
45 Guanfacine to Treat Borderline Personality Disorder Unknown status NCT00358969 Not Applicable guanfacine (Tenex)
46 A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder Unknown status NCT01033708 Not Applicable
47 Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder Unknown status NCT00131781 Not Applicable
48 Connectivity and Social Cognition in Adolescent Girls With Borderline Personality Disorder, a Pilot Study Unknown status NCT03139825 Not Applicable
49 A Double Blind Crossover Study on the Effect of MPH on Decision-making Ability of Adults With BPD Compared to Adults With ADHD and Healthy Adults Unknown status NCT01426984 Not Applicable methylphenidate
50 DBT in Borderline Personality Disorder Unknown status NCT00252031 Not Applicable
51 DBT and Escitalopram in Borderline Personality Disorder Unknown status NCT00255554 Not Applicable Escitalopram
52 Methylation Status of BDNF Gene After Dialectical Behavior Therapy in BPD Unknown status NCT02134223 Not Applicable
53 Nalmefene in Alcohol Dependence and Borderline Personality Disorder Unknown status NCT02752503 Not Applicable Nalmefene
54 Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder Unknown status NCT01683136 Not Applicable
55 Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT) Unknown status NCT01904227 Not Applicable
56 Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder Unknown status NCT00633802 Not Applicable Risperidone
57 Emotional and Non-emotional Regulation in Patients With Emotional Instability and ADHD Unknown status NCT02797873 Not Applicable
58 An Evaluation of an Adapted STEPPS Group Within Forensic Services Unknown status NCT02601391 Not Applicable
59 Skills Group for Children With Emotional Dysregulation and Their Parents Unknown status NCT01299740 Not Applicable
60 Understanding Hallucinations (Part II) Unknown status NCT02460965
61 Understanding Hallucinations (Part I) Unknown status NCT01907568
62 Transdiagnostic Treatment for Early Stage Mental Health Problems in Youth Unknown status NCT02540746 Not Applicable
63 TMS in Borderline Personality Disorder Patients Completed NCT02273674 Not Applicable
64 Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder Completed NCT02397031 Not Applicable
65 Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder Completed NCT03295838 Not Applicable
66 Depakote ER in Borderline Personality Disorder Completed NCT00222482 Not Applicable Depakote ER
67 Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder Completed NCT01952405 Not Applicable
68 Transcranial Magnetic Stimulation for Borderline Personality Disorder Completed NCT01076933 Not Applicable
69 CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSD Completed NCT02574429 Not Applicable
70 Use of Care Services by Patients With Borderline Personality Disorder Completed NCT02829658
71 Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program Completed NCT02935218 Not Applicable
72 Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder Completed NCT00714311 Not Applicable
73 Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms Completed NCT03011190 Not Applicable
74 Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder Completed NCT00467038 Not Applicable
75 MRI Imaging in Borderline Personality Disorder Completed NCT00275288
76 Effects of Motive-Oriented Therapeutic Relationship in the Early-Phase Treatment of Borderline Personality Disorder Completed NCT01896024 Not Applicable
77 Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality Disorder Completed NCT01311193 Not Applicable
78 Treatment for Borderline Personality Disorder Completed NCT00055315 Not Applicable
79 Evaluation of a Modified Dialectical Behavior Therapy Program Completed NCT01635556
80 Cognitive Rehabilitation Versus Psychoeducation in Psychosocial Functioning of Borderline Personality Disorder Completed NCT02033044 Not Applicable
81 PET Imaging and Olanzapine Treatment in Borderline Personality Disorder Completed NCT00275301 Not Applicable olanzapine
82 Staff Nurse Perceptions of MBT Skills Training for Working With BPD in AMH Completed NCT02239055
83 Hope for the Chronically Suicidal Patient Completed NCT00154154 Not Applicable
84 Cognitive Control of Negative Stimuli in BPD Completed NCT03636139 Not Applicable
85 Training of Neural Responding in BPD Completed NCT02866110 Not Applicable
86 fMRI in Impulsivity Completed NCT02755181
87 Efficacy of Dialectical Behavior Therapy Versus CAMS-informed Supportive Psychotherapy on Self Harming Behavior Completed NCT01512602 Not Applicable
88 Supportive Program for Mother With BPD Completed NCT02203708 Not Applicable
89 Effectiveness Evaluation of 'The Endeavour Programme' Completed NCT03166579 Not Applicable
90 Psychoeducation of Borderline Patients Completed NCT01719731 Not Applicable
91 Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions Completed NCT02465697 Not Applicable
92 Neural Correlates of Stress Hormones Completed NCT02523664 Not Applicable Hydrocortisone;Placebo
93 Emotional and Cognitive Self-regulation, an EEG Study Completed NCT02459340 Not Applicable
94 Efficacy of Time-limited Psychodynamic Psychotherapy and Informed Clinical Management in BPD High MHS Users Completed NCT01356069 Not Applicable
95 Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients Completed NCT00603421 Not Applicable
96 Evaluation of DBT Compared to Drug Counseling for Opiate Addicts Completed NCT00117741 Not Applicable
97 User Satisfaction Survey - Personality Disorder Service Completed NCT00202202 Not Applicable
98 Calling for Care: Cell Phones for Mood Telemetry in Teens Completed NCT01083823 Not Applicable
99 Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study Completed NCT02988037 Not Applicable
100 ERGT for Women Engaging in NSSI - an Effectiveness Study Completed NCT01986257 Not Applicable
101 Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders Completed NCT00247234 Not Applicable
102 Chrysalis Day Program Body Mass Index Study Completed NCT00202215 Not Applicable
103 Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide Completed NCT02985047 Not Applicable
104 Evaluating the Coordinated National Implementation of DBT in Ireland Completed NCT03180541 Not Applicable
105 Group Dialectical Behavioural Therapy for Mood Instability Within Bipolar Disorder: An Open Trial Completed NCT02637401
106 Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT Completed NCT03018639
107 Examining the Effectiveness of Self-Acceptance Group Therapy Completed NCT02121561 Not Applicable
108 Effects of Mindfulness Training on Emotion Regulation and Impulsivity Completed NCT03363230 Not Applicable
109 Evaluating a Novel Method of Generalizing Emotion Regulation Completed NCT01653548 Not Applicable
110 A Psychological and Behavioral Intervention for Post-Bariatric Patients Completed NCT01453517 Not Applicable
111 Commitment and Motivation in a Brief DBT Intervention for Self Harm Completed NCT02354183 Not Applicable
112 Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder Completed NCT02129790 Not Applicable
113 DBT Compared to I/GDC for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1 Completed NCT00218595 Not Applicable
114 High Risk Suicidal Behavior in Veterans Completed NCT02462694 Not Applicable
115 Collaborative Adolescent Research on Emotions and Suicide Completed NCT01528020 Not Applicable
116 Peer Support for Severe Mental Disorders Completed NCT02276469 Not Applicable
117 A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings Completed NCT03035110 Not Applicable
118 Evaluating a Peer-Facilitated Skills-Based Intervention for Caregivers of Concurrent Disordered Youth Completed NCT02243761 Not Applicable
119 Effects of Structured Skills Training Group in Treatment of ADHD in Adults Completed NCT02685254 Not Applicable
120 Fingerprinting of Impulsivity Completed NCT02722174
121 Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study Completed NCT02697019 Not Applicable
122 Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study Completed NCT02326012 Not Applicable
123 Plasticity of the Compassionate Brain Completed NCT01833104 Not Applicable
124 Transcranial Magnetic Stimulation on Dorsomedial Prefrontal Cortex in Borderline Personality Disorder Recruiting NCT03832777 Not Applicable
125 Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder Recruiting NCT03361826 Not Applicable
126 An 18-Month Psychotherapy of Borderline Personality Disorder Recruiting NCT03329677 Not Applicable
127 The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults Recruiting NCT02225600 Not Applicable 40 IU Intranasal Oxytocin;Placebo;24 IU intranasal Oxytocin
128 Change in Mindfulness in Borderline Personality Disorder Recruiting NCT03297840
129 Mechanisms of Change in Brief Treatment for Borderline Personality Disorder Recruiting NCT03717818 Not Applicable
130 Evaluating an Internet-Based Self-Management Intervention for Borderline Recruiting NCT03418142 Not Applicable
131 "The Effects of Oxytocin on Patients With Borderline Personality Disorder" Recruiting NCT01243658 Not Applicable Oxytocin
132 Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder Recruiting NCT03060902 Not Applicable
133 Dialectical Behavior Therapy for Adolescents at Rutgers University Recruiting NCT03861858 Not Applicable
134 Dialectical Behavior Therapy Rutgers University Research Program Recruiting NCT03123198 Not Applicable
135 Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD Recruiting NCT03833453 Not Applicable
136 DBT-SS for Cognitively Challenged Individuals With Deliberate Self-harm Recruiting NCT03627663 Not Applicable
137 Emotional Dysregulation in Para-suicidal Behavior Recruiting NCT03846375 Not Applicable
138 Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders Recruiting NCT03731078
139 ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse Recruiting NCT02364817
140 Effectiveness Study of a Dialectical Behavioral Treatment for Families of Adolescents With Emotional Instability Recruiting NCT02991586 Not Applicable
141 Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD) Recruiting NCT02988453 Not Applicable
142 Dissemination and Implementation Field Trial of Dialectical Behavior Therapy for Adolescents With Bipolar Disorder Recruiting NCT03661333 Not Applicable
143 Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD Recruiting NCT03833531 Not Applicable
144 Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms Recruiting NCT03601117 Not Applicable
145 Isolating Mechanisms in the Treatment of Borderline Personality Disorder Active, not recruiting NCT03408860 Not Applicable
146 Dorsomedial rTMS For Depression In Borderline Personality Disorder Active, not recruiting NCT03472638 Not Applicable
147 Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder Active, not recruiting NCT02517723 Not Applicable
148 MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial Active, not recruiting NCT02068326 Not Applicable
149 Biomarkers of Change in BPD After Metacognitive Interpersonal Therapy-standard Approach Active, not recruiting NCT02370316 Not Applicable
150 DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical &Cost Effectiveness of a 6 mo. Treatment Active, not recruiting NCT02387736 Not Applicable
151 Evaluation of AIT Study Active, not recruiting NCT02518906 Not Applicable
152 Using Smartphones for Selfmonitoring of Skill-use i Dialectical Behavior Therapy Enrolling by invitation NCT03191565 Not Applicable
153 Latent Toxoplasmosis in Females With Borderline Personality Disorder Not yet recruiting NCT03932656 Psychopharmaceuticals
154 Study of Hallucinations in Patients With Borderline Personality Disorder Not yet recruiting NCT03519035
155 DIalectical Behavior Therapy and Acceptance Commitment Therapy Short Program for BOrderLine persOnality Disorder Not yet recruiting NCT03880071 Not Applicable
156 Reactivity of Patients With Borderline Personality Disorder to an Ecological Interpersonal Stress Not yet recruiting NCT03602521 Not Applicable
157 Effects of tDCS on Impulsiveness Among People Suffering From Borderline Personality Disorder Not yet recruiting NCT03498937 Not Applicable
158 Treating Impulsivity in Adults With Probiotics Not yet recruiting NCT03495375 Not Applicable
159 Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway Not yet recruiting NCT03768674
160 Psychoeducation for Suicidal Behavior Not yet recruiting NCT03185026 Not Applicable
161 Emotional Dysregulation in Adult ADHD. Not yet recruiting NCT03494478 Not Applicable
162 Me and the Others: Expectations and Evaluation of Social Relationships Not yet recruiting NCT03764566
163 Somatic Symptom and Related Disorders: A Treatment Group and Mixed-Methods Investigation Not yet recruiting NCT03773354 Not Applicable
164 Neuropsychiatric Mechanisms of Change in Mentalization Based Treatment of Borderline Personality Disorder (MENTAB) Terminated NCT01720953
165 Mindfulness for Intense Emotions: A Feasibility Trial Withdrawn NCT02849431 Not Applicable
166 College Students Who Self-Harm Withdrawn NCT02522143 Not Applicable

Search NIH Clinical Center for Borderline Personality Disorder

Cochrane evidence based reviews: borderline personality disorder

Genetic Tests for Borderline Personality Disorder

Anatomical Context for Borderline Personality Disorder

MalaCards organs/tissues related to Borderline Personality Disorder:

42
Brain, Cortex, Amygdala, Pituitary, Testes, Prefrontal Cortex, Eye

Publications for Borderline Personality Disorder

Articles related to Borderline Personality Disorder:

(showing 3048, show less)
# Title Authors Year
1
Violent Offending in Borderline Personality Disorder and Attention Deficit/ Hyperactivity Disorder. ( 30844407 )
2019
2
Group psychotherapy for borderline personality disorder: A meta-analysis of randomized-controlled trials. ( 30869973 )
2019
3
Recent developments in psychosocial interventions for borderline personality disorder. ( 31069059 )
2019
4
Changes in facial emotion expression during a psychotherapeutic intervention for patients with borderline personality disorder. ( 31071663 )
2019
5
Staff and client perspectives of the Open Borders programme for people with borderline personality disorder. ( 31081282 )
2019
6
Inpatient Treatment for Patients With Borderline Personality Disorder. ( 31083028 )
2019
7
Effectiveness of a 5-Week Inpatient Dialectical Behavior Therapy for Borderline Personality Disorder. ( 31083031 )
2019
8
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents. ( 31089814 )
2019
9
Mental health services, care provision, and professional support for people diagnosed with borderline personality disorder: systematic review of service-user, family, and carer perspectives. ( 31099717 )
2019
10
A comprehensive evaluation of emotional responsiveness in borderline personality disorder: a support for hypersensitivity hypothesis. ( 31110772 )
2019
11
Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: A meta-analysis. ( 30500331 )
2019
12
Emotional impulsivity is connected to suicide attempts and health care utilization in patients with borderline personality disorder. ( 30503219 )
2019
13
Differential Change of Borderline Personality Disorder Traits During Dialectical Behavior Therapy for Adolescents. ( 30036173 )
2019
14
Perceived Invalidation in Adolescent Borderline Personality Disorder: An Investigation of Parallel Reports of Caregiver Responses to Negative Emotions. ( 30069665 )
2019
15
A randomized controlled trial of a mentalization-based intervention (MBT-FACTS) for families of people with borderline personality disorder. ( 29999394 )
2019
16
Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures. ( 29702176 )
2019
17
Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder - the impact of clinical severity. ( 29582581 )
2019
18
Relations of mindfulness facets with psychological symptoms among individuals with a diagnosis of obsessive-compulsive disorder, major depressive disorder, or borderline personality disorder. ( 29575447 )
2019
19
The Effectiveness of Dialectical Behavior Therapy Skills Training Group vs. Cognitive Therapy Group on Reducing Depression and Suicide Attempts for Borderline Personality Disorder in Taiwan. ( 29528807 )
2019
20
Borderline Personality Disorder: Associations Between Dimensional Personality Profiles and Self-Destructive Behaviors. ( 29505390 )
2019
21
A Randomized Controlled Trial of Group Psychoeducation for Carers of Persons With Borderline Personality Disorder. ( 29505385 )
2019
22
Mentalization in Adolescents With Borderline Personality Disorder: A Comparison With Healthy Controls. ( 29469664 )
2019
23
Reviewing the clinical significance of 'fear of abandonment' in borderline personality disorder. ( 30403145 )
2019
24
Gender differences and similarities in aggression, suicidal behaviour, and psychiatric comorbidity in borderline personality disorder. ( 30353921 )
2019
25
Borderline personality disorder traits and suicide risk: The mediating role of insomnia and nightmares. ( 30326346 )
2019
26
Screening for depression with the Edinburgh Postnatal Depression Scale and finding borderline personality disorder. ( 30309241 )
2019
27
An exploration of self-compassion and self-criticism in the context of personal recovery from borderline personality disorder. ( 30226078 )
2019
28
Psychotic symptoms in borderline personality disorder: an update. ( 30169467 )
2019
29
Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder. ( 30113988 )
2019
30
The Clinical Significance of Subthreshold Borderline Personality Disorder Features in Outpatient Youth. ( 30036169 )
2019
31
Momentary assessment of everyday physical pain in outpatients with borderline personality disorder. ( 30024195 )
2019
32
Low positive affect display mediates the association between borderline personality disorder and negative evaluations at zero acquaintance. ( 30867910 )
2019
33
Stuck in a negative me: fMRI study on the role of disturbed self-views in social feedback processing in borderline personality disorder. ( 30867073 )
2019
34
Stigma perpetuation at the interface of mental health care: a review to compare patient and clinician perspectives of stigma and borderline personality disorder. ( 30862201 )
2019
35
Getting Specific about Emotion and Self-Inflicted Injury: An Examination Across Emotion Processes in Borderline Personality Disorder. ( 30856367 )
2019
36
What Do Individuals With Borderline Personality Disorder Want From Treatment? A Study of Self-generated Treatment and Recovery Goals. ( 30849065 )
2019
37
Aberrant functional connectivity profiles of brain regions associated with salience and reward processing in female patients with borderline personality disorder. ( 30847803 )
2019
38
Mirror neuron activations in encoding of psychic pain in borderline personality disorder. ( 30844640 )
2019
39
Dependency, mood instability, and inconsequence traits for discriminating borderline personality disorder. ( 30843964 )
2019
40
Borderline Personality Disorder: Clinical Guidelines for Treatment. ( 30840560 )
2019
41
Mixed methods evaluation of an educational intervention to change mental health nurses' attitudes to people diagnosed with borderline personality disorder. ( 30830704 )
2019
42
Multimodal assessment of emotional reactivity and regulation in response to social rejection among self-harming adults with and without borderline personality disorder. ( 30816776 )
2019
43
Pharmacologic Treatment of Borderline Personality Disorder. ( 30811158 )
2019
44
Personal and parents' life stories in patients with borderline personality disorder. ( 30809831 )
2019
45
EEG-vigilance regulation in borderline personality disorder. ( 30796933 )
2019
46
Day hospital versus intensive out-patient mentalisation-based treatment for borderline personality disorder: multicentre randomised clinical trial. ( 30791963 )
2019
47
Psychophysiological stress response and memory in borderline personality disorder. ( 30788063 )
2019
48
Are Impairments in Theory of Mind Specific to Borderline Personality Disorder? ( 30785865 )
2019
49
Change of Emotional Experience in Major Depression and Borderline Personality Disorder During Psychotherapy: Associations With Depression Severity and Personality Functioning. ( 30785864 )
2019
50
Attitudes of Mental Health Staff Toward Patients With Borderline Personality Disorder: An Italian Cross-Sectional Multisite Study. ( 30785861 )
2019
51
Abandonment Psychotherapy and Psychosocial Functioning Among Suicidal Patients With Borderline Personality Disorder: A 3-Year Naturalistic Follow-Up. ( 30785852 )
2019
52
Suicidal Imagery in Borderline Personality Disorder and Major Depressive Disorder. ( 30785849 )
2019
53
Disorganized Attachment Interactions Among Young Adults With Borderline Personality Disorder, Other Diagnoses, and No Diagnosis. ( 30785838 )
2019
54
Longitudinal associations between non-suicidal self-injury and borderline personality disorder in adolescents: a literature review. ( 30783532 )
2019
55
Why go to the emergency department? Perspectives from persons with borderline personality disorder. ( 30779279 )
2019
56
The effectiveness of individual schema therapy in older adults with borderline personality disorder: Protocol of a multiple-baseline study. ( 30775612 )
2019
57
Response inhibition in borderline personality disorder: neural and behavioral correlates. ( 30772405 )
2019
58
Early maladaptive schemas and borderline personality disorder features in a non-clinical sample: A network analysis. ( 30771229 )
2019
59
Residential eating disorder outcomes associated with screening positive for substance use disorder and borderline personality disorder. ( 30746736 )
2019
60
Does a history of childhood abuse moderate the association between symptoms of posttraumatic stress disorder and borderline personality disorder in survivors of intimate partner violence? ( 30742703 )
2019
61
The Experience of Maltreatment in Young Children Whose Mothers Have Borderline Personality Disorder: Reflections in Their Narrative Representations. ( 30742556 )
2019
62
Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations. ( 30742548 )
2019
63
Borderline Personality Disorder Symptom Comorbidity Within a High Externalizing Sample: Relationship to the Internalizing-Externalizing Dimensional Structure of Psychopathology. ( 30730780 )
2019
64
Parenting in Patients with Borderline Personality Disorder, Sequelae for the Offspring and Approaches to Treatment and Prevention. ( 30729325 )
2019
65
Neuropsychological findings in recent onset schizophrenia and borderline personality disorder: a comparison study. ( 30724326 )
2019
66
Emotional Responsiveness in Borderline Personality Disorder: The Role of Basal Hyperarousal and Self-Reported Emotional Regulation. ( 30720601 )
2019
67
Optimizing borderline personality disorder treatment by incorporating significant others: A review and synthesis. ( 30714800 )
2019
68
Emotions at the border: Increased punishment behavior during fair interpersonal exchanges in borderline personality disorder. ( 30714797 )
2019
69
Metacognitive improvement and symptom change in a 3-month treatment for borderline personality disorder. ( 30712326 )
2019
70
Hallucinations in patients with borderline personality disorder: characteristics, severity, and relationship with schizotypy and loneliness. ( 30712290 )
2019
71
FKBP5 gene variants and borderline personality disorder. ( 30711865 )
2019
72
Number of Borderline Personality Disorder Criteria and Depression Predict Poor Functioning and Quality of Life in Outpatient Youth. ( 30689518 )
2019
73
Mentalizing Based on External Features in Borderline Personality Disorder Compared With Healthy Controls: The Role of Attachment Dimensions and Childhood Trauma. ( 30689514 )
2019
74
The Therapeutic Alliance Over 10 Sessions of Therapy for Borderline Personality Disorder: Agreement and Congruence Analysis and Relation to Outcome. ( 30689513 )
2019
75
Biased Attention to Facial Expressions of Ambiguous Emotions in Borderline Personality Disorder: An Eye-Tracking Study. ( 30689505 )
2019
76
Women With Borderline Personality Disorder Show Reduced Identification of Emotional Facial Expressions and a Heightened Negativity Bias. ( 30689504 )
2019
77
Relations of Maternal Borderline Personality Disorder Features With Preschooler Executive Functioning and Theory of Mind. ( 30689501 )
2019
78
Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial. ( 30689305 )
2019
79
Altered Oscillatory Responses to Feedback in Borderline Personality Disorder are Linked to Symptom Severity. ( 30689144 )
2019
80
Deaths by Suicide and Other Causes Among Patients With Borderline Personality Disorder and Personality-Disordered Comparison Subjects Over 24 Years of Prospective Follow-Up. ( 30688417 )
2019
81
Influence of betrayal trauma on borderline personality disorder traits. ( 30681038 )
2019
82
Impact of comorbid borderline personality disorder on inpatient treatment for bulimia nervosa: analysis of routine data. ( 30680217 )
2019
83
Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review. ( 30676404 )
2019
84
Effects of transcranial direct current stimulation on the cognitive control of negative stimuli in borderline personality disorder. ( 30674987 )
2019
85
Exploring the boundaries between borderline personality disorder and suicidal behavior disorder. ( 30673835 )
2019
86
Changes in mindfulness facets in a dialectical behaviour therapy skills training group program for borderline personality disorder. ( 30672590 )
2019
87
The role of attachment characteristics in dialectical behavior therapy for patients with borderline personality disorder. ( 30667573 )
2019
88
The Relationship Among Shame, Nonsuicidal Self-Injury, and Suicidal Behaviors in Borderline Personality Disorder. ( 30654709 )
2019
89
Interdiagnostician Reliability of the DSM-5 Section II and Section III Alternative Model Criteria for Borderline Personality Disorder. ( 30650010 )
2019
90
The Role of Interactional Agreeableness in Responsive Treatments for Patients With Borderline Personality Disorder. ( 30650009 )
2019
91
Longitudinal development of risk-taking and self-injurious behavior in association with late adolescent borderline personality disorder symptoms. ( 30641342 )
2019
92
Crying in borderline personality disorder patients. ( 30640050 )
2019
93
Trustworthiness appraisal deficits in borderline personality disorder are associated with prefrontal cortex, not amygdala, impairment. ( 30639176 )
2019
94
Repetitive Transcranial Magnetic Stimulation in the Treatment of a Difficult to Treat Condition, Borderline Personality Disorder. ( 30633728 )
2019
95
Effect of negative valence on assessment of self-relevance in female patients with borderline personality disorder. ( 30629628 )
2019
96
Disinhibited attachment behavior among infants of mothers with borderline personality disorder, depression, and no diagnosis. ( 30628799 )
2019
97
Mindreading abilities and borderline personality disorder: A comprehensive assessment using the Theory of Mind Assessment Scale. ( 30616131 )
2019
98
Borderline personality disorder or a disorder within the schizophrenia spectrum? A psychopathological study. ( 30600641 )
2019
99
Long-term clinical and functional course of borderline personality disorder: A meta-analysis of prospective studies. ( 30599336 )
2019
100
Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation. ( 30591402 )
2019
101
Borderline Personality Disorder, Complex Trauma, and Problems with Self and Identity: A Social-Communicative Approach. ( 31066053 )
2019
102
Reduced mentalizing in patients with bulimia nervosa and features of borderline personality disorder: A case-control study. ( 31060534 )
2019
103
Outcomes for 18 to 25-year-olds with borderline personality disorder in a dedicated young adult only DBT programme compared to a general adult DBT programme for all ages 18. ( 31044536 )
2019
104
Differential Perception of Sharp Pain in Patients with Borderline Personality Disorder. ( 31034113 )
2019
105
Inpatient adolescents with borderline personality disorder features: Identity diffusion and narrative incoherence. ( 31033329 )
2019
106
Variability in Suicidal Ideation is Associated with Affective Instability in Suicide Attempters with Borderline Personality Disorder. ( 31013205 )
2019
107
Neural Signatures of Social Inclusion in Borderline Personality Disorder Versus Non-suicidal Self-injury. ( 31011853 )
2019
108
Hypermentalizing as a marker of borderline personality disorder in Italian adolescents: a cross-cultural replication of Sharp and colleagues' (2011) findings. ( 31007932 )
2019
109
Carer perspectives of people diagnosed with borderline personality disorder: A scoping review of emergency care responses. ( 30998870 )
2019
110
Dependency, mood instability, and inconsequence traits for discriminating borderline personality disorder. ( 30994782 )
2019
111
Affective interference in borderline personality disorder: The lethality of suicidal behavior predicts functional brain profiles. ( 30991253 )
2019
112
Whole-brain microstructural white matter alterations in borderline personality disorder patients. ( 30989833 )
2019
113
Effects of Childhood Maltreatment on Social Cognition and Brain Functional Connectivity in Borderline Personality Disorder Patients. ( 30988667 )
2019
114
Borderline personality disorder is associated with an increased risk of sexually transmitted infections: A nationwide population-based cohort study in Taiwan. ( 30981998 )
2019
115
Impact of infant crying on mothers with a diagnosis of borderline personality disorder: A qualitative study. ( 30964954 )
2019
116
Nonacceptance of negative emotions in women with borderline personality disorder: association with neuroactivity of the dorsal striatum ( 30964611 )
2019
117
Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. ( 30953536 )
2019
118
Autobiographical memories, identity disturbance and brain functioning in patients with borderline personality disorder: An fMRI study. ( 30949597 )
2019
119
Emotional Competence and Coping Mechanisms in Croatian Women with Borderline Personality Disorder: the Role of Attachment. ( 30948694 )
2019
120
The Modulating Role of Self-Referential Stimuli and Processes in the Effect of Stress and Negative Emotion on Inhibition Processes in Borderline Personality Disorder: Proposition of a Model to Integrate the Self-Concept and Inhibition Processes. ( 30935039 )
2019
121
Degree of Correspondence Between Retrospective and Proximal Reports of Borderline Personality Disorder Symptoms, Symptom Triggers, and Emotions. ( 30920939 )
2019
122
Interpersonal Problems in Borderline Personality Disorder: Associations with Mentalizing, Emotion Regulation, and Impulsiveness. ( 30920937 )
2019
123
Risk Factors for Borderline Personality Disorder in Adolescents. ( 30920936 )
2019
124
The link between rejection sensitivity and borderline personality disorder: A systematic review and meta-analysis. ( 30900278 )
2019
125
Borderline personality disorder and ICD-11: A chance for change. ( 30897927 )
2019
126
Implicit and explicit self-concept of neuroticism in borderline personality disorder. ( 30896322 )
2019
127
Precursors of the emotional cascade model of borderline personality disorder: The role of neuroticism, childhood emotional vulnerability, and parental invalidation. ( 30896201 )
2019
128
Cognitive heuristics in borderline personality disorder across treatment: A longitudinal non-parametric analysis. ( 30887510 )
2019
129
Whole-brain functional connectivity during script-driven aggression in borderline personality disorder. ( 30885789 )
2019
130
Self-reported impulsivity in women with borderline personality disorder: the role of childhood maltreatment severity and emotion regulation difficulties. ( 30873282 )
2019
131
Moving Toward Connectedness - A Qualitative Study of Recovery Processes for People With Borderline Personality Disorder. ( 30873097 )
2019
132
Differentiating bipolar disorder from borderline personality disorder: Diagnostic accuracy of the difficulty in emotion regulation scale and personality inventory for DSM-5. ( 30699870 )
2019
133
Screening for Borderline Personality Disorder in Psychiatric Outpatients With Major Depressive Disorder and Bipolar Disorder. ( 30677270 )
2019
134
Bipolar Disorder and Comorbid Borderline Personality Disorder: Patient Characteristics and Outcomes in US Hospitals. ( 30646620 )
2019
135
Common and distinct patterns of grey matter alterations in borderline personality disorder and bipolar disorder: voxel-based meta-analysis. ( 30846010 )
2019
136
Impulsivity and its association with childhood trauma experiences across bipolar disorder, attention deficit hyperactivity disorder and borderline personality disorder. ( 30336349 )
2019
137
Dimensions of Impulsivity in Healthy People, Patients with Borderline Personality Disorder, and Patients with Attention-Deficit/Hyperactivity Disorder. ( 30628513 )
2019
138
Rejection Sensitivity and Borderline Personality Disorder Features: The Mediating Roles of Attachment Anxiety, Need to Belong, and Self-Criticism. ( 30650007 )
2019
139
Longitudinal associations among primary and secondary psychopathic traits, anxiety, and borderline personality disorder features across adolescence. ( 30628800 )
2019
140
Symptom, alexithymia and self-image outcomes of Mentalisation-based treatment for borderline personality disorder: a naturalistic study. ( 29890960 )
2018
141
Cognitive distortions in anorexia nervosa and borderline personality disorder. ( 29197752 )
2018
142
Emotional reactivity to appraisals in patients with a borderline personality disorder: a daily life study. ( 30459949 )
2018
143
Schema therapy for borderline personality disorder: A qualitative study of patients' perceptions. ( 30462650 )
2018
144
Facets of identity disturbance reported by patients with borderline personality disorder and personality-disordered comparison subjects over 20 years of prospective follow-up. ( 30469092 )
2018
145
Different Clinical Presentations in Eating Disorder Patients with Non-Suicidal Self-Injury Based on the Co-Occurrence of Borderline Personality Disorder. ( 30479820 )
2018
146
Exploratory comparison of auditory verbal hallucinations and other psychotic symptoms among youth with borderline personality disorder or schizophrenia spectrum disorder. ( 30485670 )
2018
147
No Effect of Lamotrigine in Subgroups of Patients With Borderline Personality Disorder: Response to Smith. ( 30501417 )
2018
148
An Opportunity to Report Closer-to-Efficacy Findings in a Study of Lamotrigine for Borderline Personality Disorder. ( 30501419 )
2018
149
Change in Emotional and Theory of Mind Processing in Borderline Personality Disorder: A Pilot Study. ( 30507735 )
2018
150
Psychotic symptoms in adolescents with borderline personality disorder features. ( 30511234 )
2018
151
Dissociative states in borderline personality disorder and their relationships to psychotropic medication. ( 30538483 )
2018
152
Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies. ( 30538595 )
2018
153
Autobiographical Memory Impairment in Borderline Personality Disorder: A Quantitative Meta-analysis Interpreted in Terms of the CaR-FA-X Model. ( 30036172 )
2018
154
Differential Valuation and Learning From Social and Nonsocial Cues in Borderline Personality Disorder. ( 30041970 )
2018
155
A systematic review of negative parenting practices predicting borderline personality disorder: Are we measuring biosocial theory's 'invalidating environment'? ( 30055510 )
2018
156
Medication Management for Patients With Borderline Personality Disorder. ( 30064243 )
2018
157
A psychoeducational group intervention for family and friends of youth with borderline personality disorder features: protocol for a randomised controlled trial. ( 30065842 )
2018
158
Specialized psychotherapies for adults with borderline personality disorder: A systematic review and meta-analysis. ( 30091375 )
2018
159
Outcome Trajectories and Prognostic Factors for Suicide and Self-Harm Behaviors in Patients With Borderline Personality Disorder Following One Year of Outpatient Psychotherapy. ( 28910214 )
2018
160
Substance Misuse Is Associated With Increased Psychiatric Severity Among Treatment-Seeking Individuals With Borderline Personality Disorder. ( 28910215 )
2018
161
Reduced white matter integrity in borderline personality disorder: A diffusion tensor imaging study. ( 28922736 )
2018
162
Personality organization and its association with clinical and functional features in borderline personality disorder. ( 28923434 )
2018
163
Subgroups of Adolescent Girls With Borderline Personality Disorder Symptoms. ( 28926303 )
2018
164
Substance Use in Youth With Borderline Personality Disorder. ( 28926304 )
2018
165
Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results. ( 28927866 )
2018
166
Estimating the prevalence of borderline personality disorder in mothers involved in youth protection services. ( 28944592 )
2018
167
Models of borderline personality disorder: recent advances and new perspectives. ( 29049100 )
2018
168
Advances in transference-focused psychotherapy derived from the study of borderline personality disorder: clinical insights with a focus on mechanism. ( 29065381 )
2018
169
Clinical utility of the DSM-5 alternative model for borderline personality disorder: Differential diagnostic accuracy of the BFI, SCID-II-PQ, and PID-5. ( 29069625 )
2018
170
Schemas and modes in borderline personality disorder: The mistrustful, shameful, angry, impulsive, and unhappy child. ( 29101874 )
2018
171
Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study. ( 29111076 )
2018
172
Effect of maternal borderline personality disorder on adolescents' experience of maltreatment and adolescent borderline features. ( 29120194 )
2018
173
Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image Study. ( 29120277 )
2018
174
What is the clinical significance of chronic emptiness in borderline personality disorder? ( 29034695 )
2018
175
Substance-induced psychotic symptoms in Borderline Personality Disorder among substance use disorder samples in Spain. ( 29227894 )
2018
176
Maternal psychological control, maternal borderline personality disorder, and adolescent borderline features. ( 29239626 )
2018
177
Clinical severity as a moderator of outcome in psychodynamic and dialectical behavior therapies for borderline personality disorder. ( 29239627 )
2018
178
Individuals with Borderline Personality Disorder show larger preferred social distance in live dyadic interactions. ( 29248760 )
2018
179
Always on guard: emotion regulation in women with borderline personality disorder compared to nonpatient controls and patients with cluster-C personality disorder. ( 29252164 )
2018
180
Premature Termination of Psychotherapy in Patients With Borderline Personality Disorder: A Cluster-Analytic Study. ( 29252927 )
2018
181
Schema modes and dissociation in borderline personality disorder/traits in adolescents or young adults. ( 29272751 )
2018
182
The effects of oxytocin on social cognition in borderline personality disorder. ( 29273344 )
2018
183
Process and impact of dialectical behaviour therapy: A systematic review of perceptions of clients with a diagnosis of borderline personality disorder. ( 29034599 )
2018
184
Past, present, and future of genetic research in borderline personality disorder. ( 29032046 )
2018
185
Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism. ( 29028643 )
2018
186
Interpersonal barriers to recovery from borderline personality disorder: A qualitative analysis of patient perspectives. ( 29024577 )
2018
187
Anger and depressive ruminations as predictors of dysregulated behaviours in borderline personality disorder. ( 29024226 )
2018
188
Current directions in laboratory studies of personality pathology: Examples from borderline personality disorder, psychopathy, and schizotypy. ( 29323528 )
2018
189
Neural correlates of emotional action control in anger-prone women with borderline personality disorder. ( 29336775 )
2018
190
Features of borderline personality disorder as a mediator of the relation between childhood traumatic experiences and psychosis-like experiences in patients with mood disorder. ( 29353179 )
2018
191
Resting-state functional connectivity of neurotransmitter producing sites in female patients with borderline personality disorder. ( 29355588 )
2018
192
On the potential for iatrogenic effects of psychiatric crisis services: The example of dialectical behavior therapy for adult women with borderline personality disorder. ( 29369662 )
2018
193
A mentalization-based approach to common factors in the treatment of borderline personality disorder. ( 28985628 )
2018
194
Remnants and changes in facial emotion processing in women with remitted borderline personality disorder: an EEG study. ( 28956145 )
2018
195
Alliance Rupture and Resolution in Dialectical Behavior Therapy for Borderline Personality Disorder. ( 29388901 )
2018
196
Attachment-Related Regulatory Processes Moderate the Impact of Adverse Childhood Experiences on Stress Reaction in Borderline Personality Disorder. ( 29388902 )
2018
197
Clinical Components of Borderline Personality Disorder and Personality Functioning. ( 29393279 )
2018
198
Treating borderline personality disorder with oxytocin: An enthusiastic note of caution. Commentary to Servan et al. The effect of oxytocin in borderline personality disorder. ( 29402386 )
2018
199
Mentalization-Based Treatment for Concurrent Borderline Personality Disorder and Substance Use Disorder: A Randomized Controlled Feasibility Study. ( 29402870 )
2018
200
Behavioural mimicry and loneliness in borderline personality disorder. ( 29407356 )
2018
201
Borderline personality disorder and sexual abuse: A systematic review. ( 29407572 )
2018
202
Fear of Being Laughed at in Borderline Personality Disorder. ( 29410640 )
2018
203
Affect dysregulation, psychoform dissociation, and adult relational fears mediate the relationship between childhood trauma and complex posttraumatic stress disorder independent of the symptoms of borderline personality disorder. ( 29410773 )
2018
204
Psychosocial stress differentially affects emotional empathy in women with borderline personality disorder and healthy controls. ( 29417987 )
2018
205
Improving functional outcomes in women with borderline personality disorder and PTSD by changing PTSD severity and post-traumatic cognitions. ( 29448136 )
2018
206
Emotional availability in mothers with borderline personality disorder and mothers with remitted major depression is differently associated with psychopathology among school-aged children. ( 29453011 )
2018
207
Meaningful Ways of Understanding and Measuring Change for People with Borderline Personality Disorder: A Thematic Analysis. ( 29455697 )
2018
208
Pain Perception and Body Awareness Among Individuals With Borderline Personality Disorder. ( 28902571 )
2018
209
Borderline personality disorder and polycystic ovary syndrome: A review of the literature. ( 28891300 )
2018
210
Endogenous oxytocin is associated with the experience of compassion and recalled upbringing in Borderline Personality Disorder. ( 28881460 )
2018
211
Dialectical behavior therapy skills training affects defense mechanisms in borderline personality disorder: An integrative approach of mechanisms in psychotherapy. ( 30005584 )
2018
212
Effectiveness of step-down versus outpatient dialectical behaviour therapy for patients with severe levels of borderline personality disorder: a pragmatic randomized controlled trial. ( 30002832 )
2018
213
Partners of Individuals with Borderline Personality Disorder: A Systematic Review of the Literature Examining Their Experiences and the Supports Available to Them. ( 29975337 )
2018
214
Men and women with borderline personality disorder resident in Dutch special psychiatric units in prisons: A descriptive and comparative study. ( 29971844 )
2018
215
Abnormal Sensitization of Neural and Behavioral Responses to Socially Relevant Images in Individuals With Borderline Personality Disorder: Implications for Guiding More Effective Targeting of Treatments. ( 29961366 )
2018
216
Sensitization of the Neural Salience Network to Repeated Emotional Stimuli Following Initial Habituation in Patients With Borderline Personality Disorder. ( 29961363 )
2018
217
Individuals with Borderline Personality Disorder manifest cognitive biases implicated in psychosis. ( 29960939 )
2018
218
Borderline personality disorder is equally trait-like and state-like over ten years in adult psychiatric patients. ( 29952598 )
2018
219
Construct Validity of the McLean Screening Instrument for Borderline Personality Disorder in Two Singaporean Samples. ( 29949444 )
2018
220
Reduced amygdala reactivity and impaired working memory during dissociation in borderline personality disorder. ( 28526931 )
2018
221
How do you choose and how well does it work?: the selection and effectiveness of emotion regulation strategies and their relationship with borderline personality disorder feature severity. ( 28553745 )
2018
222
Mentalizing as a mechanism of change in the treatment of patients with borderline personality disorder: A parallel process growth modeling approach. ( 28569524 )
2018
223
Borderline personality disorder features and drinking, cannabis, and prescription opioid motives: Differential associations across substance and sex. ( 29945027 )
2018
224
Emotional responses to receiving peer feedback on opinions in borderline personality disorder. ( 29927294 )
2018
225
Exclusion-Proneness in Borderline Personality Disorder Inpatients Impairs Alliance in Mentalization-Based Group Therapy. ( 29910754 )
2018
226
Treatment of a Patient with Borderline Personality Disorder Based on Phase-Oriented Model of Eye Movement Desensitization and Reprocessing (EMDR): A Case Report. ( 29892320 )
2018
227
Erratum - Borderline Personality Disorder Symptom Severity and Sexually Transmitted Infection and HIV Risk in African American Incarcerated Men. ( 29889162 )
2018
228
Dissecting the elements of borderline personality disorder. ( 29878704 )
2018
229
Positive psychotic symptoms in patients with borderline personality disorder: a valuable but still not completely understood clinical marker of the illness. ( 29873564 )
2018
230
Perimenstrual exacerbation of symptoms in borderline personality disorder: evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System. ( 29860953 )
2018
231
Childhood maltreatment and its link to borderline personality disorder features in children: A systematic review approach. ( 28617046 )
2018
232
Predictors of substance use in youth with borderline personality disorder. ( 28627903 )
2018
233
Randomized Controlled Trial of Web-Based Psychoeducation for Women With Borderline Personality Disorder. ( 28703950 )
2018
234
Psychiatrists' motives for practising in-patient compulsory care of patients with borderline personality disorder (BPD). ( 29853014 )
2018
235
Training in Good Psychiatric Management for Borderline Personality Disorder in Residency: An Aide to Learning Supportive Psychotherapy for Challenging-to-Treat Patients. ( 29809114 )
2018
236
Perimenstrual exacerbation of symptoms in borderline personality disorder: evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System. ( 29804553 )
2018
237
Borderline personality disorder. ( 29795363 )
2018
238
Borderline personality disorder. ( 29795174 )
2018
239
Child abuse potential in mothers with early life maltreatment, borderline personality disorder and depression. ( 29792587 )
2018
240
Relationship between effortful control and facets of mindfulness in meditators, non-meditators and individuals with borderline personality disorder. ( 29781245 )
2018
241
Patterns of Non-Suicidal Self-Injury and Their Relationship with Suicide Attempts in Youth with Borderline Personality Disorder. ( 28759336 )
2018
242
Diagnosis and Treatment of Borderline Personality Disorder in the College Mental Health Setting. ( 29777413 )
2018
243
Borderline personality disorder: Implications and best practice recommendations. ( 29757830 )
2018
244
Patterns of Emotional Availability between Mothers and Young Children: Associations with Risk Factors for Borderline Personality Disorder. ( 29755295 )
2018
245
Borderline personality disorder symptoms and affective responding to perceptions of rejection and acceptance from romantic versus nonromantic partners. ( 29745698 )
2018
246
The Psychodynamic Treatment of Borderline Personality Disorder: An Introduction to Transference-Focused Psychotherapy. ( 29739521 )
2018
247
Suicidal Ideation and Skill Use During In-patient Dialectical Behavior Therapy for Borderline Personality Disorder. A Diary Card Study. ( 29731724 )
2018
248
Early life stress, resilience and emotional dysregulation in major depressive disorder with comorbid borderline personality disorder. ( 29730510 )
2018
249
Case Study Application for Psychopharmacology With Borderline Personality Disorder. ( 29715373 )
2018
250
What changes when? The course of improvement during a stage-based treatment for suicidal and self-injuring women with borderline personality disorder and PTSD. ( 27808001 )
2018
251
The physiological orienting response in female adolescents with borderline personality disorder. ( 29709541 )
2018
252
Clinical outcomes of a stepped care program for borderline personality disorder. ( 29709109 )
2018
253
Evaluation of the relationship between cognitive functioning in patients with borderline personality disorder and their general functioning. ( 29704412 )
2018
254
Is 'subthreshold' bipolar II disorder more difficult to differentiate from borderline personality disorder than formal bipolar II disorder? ( 29689499 )
2018
255
Assessing the marks of change: how psychotherapy alters the brain structure in women with borderline personality disorder. ( 29688873 )
2018
256
Neural correlates of emotional action control in anger-prone women with borderline personality disorder. ( 29688872 )
2018
257
An exploration of values among consumers seeking treatment for borderline personality disorder. ( 29686876 )
2018
258
Amygdala structure and aggressiveness in borderline personality disorder. ( 27878376 )
2018
259
Social disadvantage and borderline personality disorder: A study of social networks. ( 27936840 )
2018
260
Corrigendum to "A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: A randomized controlled trial" [(J. Behav. Ther. Exp. Psychiatr.) 40 (2) (June 2009) 317-328]. ( 29680679 )
2018
261
Neurobiological Mechanisms Mediating Emotion Dysregulation as Targets of Change in Borderline Personality Disorder. ( 29672301 )
2018
262
Does Post-operative Psychotherapy Contribute to Improved Comorbidities in Bariatric Patients with Borderline Personality Disorder Traits and Bulimia Tendencies? ( 29671121 )
2018
263
A Non-linear Predictive Model of Borderline Personality Disorder Based on Multilayer Perceptron. ( 29670562 )
2018
264
A naturalistic longitudinal study of extended inpatient treatment for adults with borderline personality disorder: An examination of treatment response, remission and deterioration. ( 29665515 )
2018
265
The relation of borderline personality disorder to aggression, victimization, and institutional misconduct among prisoners. ( 29660674 )
2018
266
Emotional intelligence in patients with posttraumatic stress disorder, borderline personality disorder and healthy controls. ( 29660571 )
2018
267
Staff perceptions of borderline personality disorder and recovery: A Q-sort method approach. ( 29659031 )
2018
268
Borderline personality disorder and the ethics of risk management: The action/consequence model. ( 28100114 )
2018
269
Lamotrigine for people with borderline personality disorder: a RCT. ( 29651981 )
2018
270
Borderline personality disorder: an adaptation of the Taiwan short version of the screening inventory into Brazilian Portuguese. ( 29641649 )
2018
271
Heightened Salience of Anger and Aggression in Female Adolescents With Borderline Personality Disorder-A Script-Based fMRI Study. ( 29632476 )
2018
272
The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial. ( 29621901 )
2018
273
Clients' experiences of treatment and recovery in borderline personality disorder: A meta-synthesis of qualitative studies. ( 28140762 )
2018
274
Orbitofrontal overactivation in reward processing in borderline personality disorder: the role of non-suicidal self-injury. ( 28247156 )
2018
275
Borderline Personality Disorder Features Are Associated with Concurrent Pain-Related Disability in a Chronic Pain Sample. ( 29618083 )
2018
276
The association between locus of control, emotion regulation and borderline personality disorder features. ( 29611336 )
2018
277
Psychopharmacology for Borderline Personality Disorder. ( 29596715 )
2018
278
Interoception and Its Interaction with Self, Other, and Emotion Processing: Implications for the Understanding of Psychosocial Deficits in Borderline Personality Disorder. ( 29594580 )
2018
279
Comorbid Diagnosis of Psychotic Disorders in Borderline Personality Disorder: Prevalence and Influence on Outcome. ( 29593589 )
2018
280
The role of maternal care in borderline personality disorder and dependent life stress. ( 29588857 )
2018
281
Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder. ( 29578497 )
2018
282
Current Understanding of the Neural Mechanisms of Dissociation in Borderline Personality Disorder. ( 29577011 )
2018
283
Are emotional action tendencies and attentional bias related to temperament dimensions in patients with borderline personality disorder? ( 29576411 )
2018
284
Borderline personality disorder and mental health care utilization: The role of self-harm. ( 28301180 )
2018
285
Affective startle modulation in young people with first-presentation borderline personality disorder. ( 29571079 )
2018
286
Student health professionals' attitudes and experience after watching "Ida's Diary", a first-person account of living with borderline personality disorder: Mixed methods study. ( 29567593 )
2018
287
Cognitive Emotion Regulation Strategies in Borderline Personality Disorder: Diagnostic Comparisons and Associations with Potentially Harmful Behaviors. ( 29566390 )
2018
288
Theories and Treatment of Borderline Personality Disorder: Commentary on Gunderson et al. ( 29561725 )
2018
289
The Five-Factor Model Is a Competing Theory of Borderline Personality Disorder: Commentary on Gunderson et al. ( 29561724 )
2018
290
Competing Theories of Borderline Personality Disorder. ( 29561723 )
2018
291
Introduction to the Special Section on Theories of Borderline Personality Disorder. ( 29561722 )
2018
292
Pattern of social cognition deficits in individuals with borderline personality disorder. ( 29554632 )
2018
293
Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial. ( 29549516 )
2018
294
Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. ( 29546791 )
2018
295
Childhood trauma and dissociative symptoms predict frontal EEG asymmetry in borderline personality disorder. ( 29543578 )
2018
296
Comparison of early maladaptive schemas between borderline personality disorder and chronic depression. ( 29542265 )
2018
297
Behavioral and Neurobiological Correlates of Disturbed Emotion Processing in Borderline Personality Disorder. ( 29539627 )
2018
298
Borderline personality disorder: does its clinical features show specificity to differing developmental risk factors? ( 29533077 )
2018
299
Borderline personality disorder symptoms in treatment-naïve actively drinking alcoholics. ( 29529507 )
2018
300
Interpersonal stressors and negative affect in individuals with borderline personality disorder and community adults in daily life: A replication and extension. ( 29528672 )
2018
301
Low Vocational Outcome Among People Diagnosed With Borderline Personality Disorder During First Admission to Mental Health Services in Denmark: A Nationwide 9-Year Register-Based Study. ( 29505387 )
2018
302
Risk stratification for the early diagnosis of borderline personality disorder using psychiatric co-morbidities. ( 27587229 )
2018
303
Correlates of autistic traits among patients with borderline personality disorder. ( 29500962 )
2018
304
Exposure to interpersonal violence and risk of post-traumatic stress disorder among women with borderline personality disorder. ( 29494867 )
2018
305
Improving Family Functioning to (Hopefully) Improve Treatment Efficacy of Borderline Personality Disorder: An Opportunity Not to Dismiss. ( 29486480 )
2018
306
The co-occurrence of autistic traits and borderline personality disorder traits is associated to increased suicidal ideation in nonclinical young adults. ( 29486417 )
2018
307
Stress reactivity and pain-mediated stress regulation in remitted patients with borderline personality disorder. ( 29484266 )
2018
308
Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder. ( 29482597 )
2018
309
Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. ( 29478425 )
2018
310
Ambulatory Assessment of Borderline Personality Disorder. ( 29471296 )
2018
311
10-Year Outcome of Suicidal Behavior in Borderline Personality Disorder. ( 29469667 )
2018
312
A Neuroscience-Oriented Research Approach to Borderline Personality Disorder. ( 29469663 )
2018
313
Grandiose and Vulnerable Narcissism in Borderline Personality Disorder. ( 29466803 )
2018
314
Abnormalities in gray matter volume in patients with borderline personality disorder and their relation to lifetime depression: A VBM study. ( 29466364 )
2018
315
Dynamic associations between borderline personality disorder and stressful life events over five years in older adults. ( 29461847 )
2018
316
Borderline personality disorder affective instability: What you know impacts how you feel. ( 29461071 )
2018
317
Borderline Personality Disorder in Adolescence as a Generalization of Disorganized Attachment. ( 30459673 )
2018
318
Consider others better than yourself: Social decision-making and partner preference in Borderline Personality Disorder. ( 30458960 )
2018
319
Borderline Personality Disorder (BPD): In the Midst of Vulnerability, Chaos, and Awe. ( 30453675 )
2018
320
Borderline Personality Disorder. ( 30447736 )
2018
321
Psychotherapy for Borderline Personality Disorder in Adolescents. ( 30447735 )
2018
322
Treatment of Borderline Personality Disorder. ( 30447734 )
2018
323
Borderline Personality Disorder: Barriers to Borderline Personality Disorder Treatment and Opportunities for Advocacy. ( 30447733 )
2018
324
The Longitudinal Course of Borderline Personality Disorder. ( 30447732 )
2018
325
Attachment and Borderline Personality Disorder. ( 30447730 )
2018
326
The Neurobiology of Borderline Personality Disorder. ( 30447729 )
2018
327
Social Cognition and Borderline Personality Disorder: Splitting and Trust Impairment Findings. ( 30447728 )
2018
328
Comorbidity of Borderline Personality Disorder: Current Status and Future Directions. ( 30447726 )
2018
329
Differential Diagnosis of Borderline Personality Disorder. ( 30447725 )
2018
330
Community and Clinical Epidemiology of Borderline Personality Disorder. ( 30447724 )
2018
331
Conceptual Models of Borderline Personality Disorder, Part 2: A Process Approach and Its Implications. ( 30447723 )
2018
332
Conceptual Models of Borderline Personality Disorder, Part 1: Overview of Prevailing and Emergent Models. ( 30447722 )
2018
333
A New Therapeutic Group To Help Women With Borderline Personality Disorder and Their Infants. ( 30427820 )
2018
334
Differential Susceptibility to the Environment and Borderline Personality Disorder. ( 30407236 )
2018
335
Role of Electroconvulsive Therapy in Major Depressive Disorder with Borderline Personality Disorder: Case Report and Literature Review. ( 30405987 )
2018
336
Metacognitive Reflection and Insight Therapy (MERIT): Application to a Long-Term Therapy Case of Borderline Personality Disorder. ( 30400764 )
2018
337
Posttraumatic Stress Disorder in Patients With Borderline Personality Disorder: Treatment Outcomes and Mediators. ( 30398678 )
2018
338
Self-injuring adolescent girls exhibit insular cortex volumetric abnormalities that are similar to those seen in adults with borderline personality disorder. ( 30394252 )
2018
339
Does response to the STEPPS program differ by sex, age, or race in offenders with borderline personality disorder? ( 30393119 )
2018
340
Rest, Reactivity, and Recovery: A Psychophysiological Assessment of Borderline Personality Disorder. ( 30386267 )
2018
341
The Italian version of the Reflective Functioning Questionnaire: Validity data for adults and its association with severity of borderline personality disorder. ( 30383803 )
2018
342
A Transgender Woman With Intellectual Disability and Borderline Personality Disorder. ( 30380931 )
2018
343
Enduring Effects of One-Day Training in Good Psychiatric Management on Clinician Attitudes About Borderline Personality Disorder. ( 30371640 )
2018
344
Isolating the effect of opposite action in borderline personality disorder: A laboratory-based alternating treatment design. ( 30366576 )
2018
345
Dialectical Behavior Therapy for Men With Borderline Personality Disorder and Antisocial Behavior: A Clinical Trial. ( 30355023 )
2018
346
Emotional Reactivity in Borderline Personality Disorder: Theoretical Considerations Based on a Meta-Analytic Review of Laboratory Studies. ( 30355020 )
2018
347
Negative evaluation of individuals with borderline personality disorder at zero acquaintance. ( 30342222 )
2018
348
PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial. ( 30340474 )
2018
349
Clozapine for the Management of Suicidal Behavior in Borderline Personality Disorder Complicated by a Cancer Diagnosis: A Case Report and Review of the Literature. ( 30334867 )
2018
350
Somatosensory Stimulus Intensity Encoding in Borderline Personality Disorder. ( 30327632 )
2018
351
Experiences of family members who have a relative diagnosed with borderline personality disorder. ( 30326706 )
2018
352
Stigma, Emotion Appraisal, and the Family Environment as Predictors of Carer Burden for Relatives of Individuals Who Meet the Diagnostic Criteria for Borderline Personality Disorder. ( 30307828 )
2018
353
Borderline Personality Disorder and Violence Toward Self and Others: A National Study. ( 30307827 )
2018
354
Respiratory Sinus Arrhythmia Mediates Links Between Borderline Personality Disorder Symptoms and Both Aggressive and Violent Behavior. ( 30307825 )
2018
355
All-Cause Mortality of Hospital-Treated Borderline Personality Disorder: A Nationwide Cohort Study. ( 30307824 )
2018
356
Cross-Domain Assessment of Distress Intolerance: Associations With Borderline Personality Disorder Features. ( 30307823 )
2018
357
Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder. ( 30303061 )
2018
358
Clinical, personality, and neurodevelopmental phenotypes in borderline personality disorder: a family study. ( 30303056 )
2018
359
Protocol for the REVISIT-BPD Trial, a Randomized Controlled Trial Testing the Effectiveness of an Internet-Based Self-Management Intervention in the Treatment of Borderline Personality Disorder (BPD). ( 30298024 )